【结 构 式】 |
【分子编号】15141 【品名】(1R,2S)-(-)-2-Amino-1,2-diphenylethanol; (1S,2R)-2-amino-1,2-diphenyl-1-ethanol 【CA登记号】23190-16-1 |
【 分 子 式 】C14H15NO 【 分 子 量 】213.27924 【元素组成】C 78.84% H 7.09% N 6.57% O 7.5% |
合成路线1
该中间体在本合成路线中的序号:(XVII)The chiral intermediate (1R,2S)-N-(tert-butoxycarbonyl)-2-fluorocyclopropylamine (III) can also be obtained as follows: 2) The cyclization of (1S,2R)-2-amino-1,2-diphenylethanol (XVII) with trichloromethyl chloroformate and triethylamine in dichloromethane gives (4R,5S)-4,5-diphenyloxazolidin-2-one (XVIII), which is treated with 1,1-dimethoxyethane and an acid catalyst, yielding the 1-methoxyethyl derivative (XIX). The heat treatment (150 C) of (XIX) affords the corresponding vinyl derivative (XX), which is cyclized with fluorodiiodomethane and diethyl zinc (a fluorocarbenoid compound) in a preferentially cis-way to afford the cyclopropyl-oxazolidinone (XXI), purified by column chromatography. The hydrogenolysis of (XXI) with H2 over Pd/C in acetic acid gives (1R,2S)-2-fluorocyclopropylamine (XXII), which is finally converted into (III) by reaction with tert-butoxycarbonyl anhydride and triethylamine in THF.
【1】 Castaner, J.; Graul, A.; Prous, J.; DU-6859. Drugs Fut 1994, 19, 9, 827. |
【2】 Tamura, O.; Hashimoto, M.; Kobayashi, Y.; Katoh, T.; Nakatani, K.; Kamada, M.; Hayakawa, I.; Akiba, T.; Terashima, S.; Asymmetric synthesis of (1R,2S)-2-fluorocyclopropylamine, the key intermediate of the new generation of quinolonecarboxylic acid, DU-6859. Tetrahedron Lett 1992, 33, 24, 3487-90. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(III) | 15127 | tert-butyl N-[(1R,2S)-2-fluorocyclopropyl]carbamate | 127199-16-0 | C8H14FNO2 | 详情 | 详情 |
(XVII) | 15141 | (1R,2S)-(-)-2-Amino-1,2-diphenylethanol; (1S,2R)-2-amino-1,2-diphenyl-1-ethanol | 23190-16-1 | C14H15NO | 详情 | 详情 |
(XVIII) | 15142 | (4R,5S)-4,5-Diphenyl-1,3-oxazolan-2-one; (4S,5R)-(-)-4,5-Diphenyl-2-oxazolidinone | 86286-50-2 | C15H13NO2 | 详情 | 详情 |
(XIX) | 15143 | (4R,5S)-3-[(1R)-1-Methoxyethyl]-4,5-diphenyl-1,3-oxazolan-2-one | C18H19NO3 | 详情 | 详情 | |
(XX) | 15144 | (4R,5S)-4,5-diphenyl-3-vinyl-1,3-oxazolan-2-one | C17H15NO2 | 详情 | 详情 | |
(XXI) | 15145 | (4R,5S)-3-[(1R,2S)-2-fluorocyclopropyl]-4,5-diphenyl-1,3-oxazolan-2-one | C18H16FNO2 | 详情 | 详情 | |
(XXII) | 15146 | (1R,2S)-2-Fluorocyclopropanamine; (1R,2S)-2-Fluorocyclopropylamine | C3H6FN | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(II)Chiral resolution of protected dl-thiopropionic acid derivative (I) is performed by first condensation with (1R,2S)-(-)-2-amino-1,2-diphenyl ethanol in acetonitrile followed by diastereomer separation and finally hydrolysis of the optically active salt to afford the desired stereoisomer (S)-(II). Activation of (S)-(II) with oxalyl chloride in dichloromethane and subsequent coupling to L-isoglutamine derivative (III) in CH2Cl2 in the presence of pyridine provides amide (S)-(IV), which is finally converted into the target product by alkaline hydrolysis with LiOH in THF.
【1】 Katsube, N.; Nakai, H.; Nagao, Y.; Sakai, Y.; Senokuchi, K.; Kawamura, M.; New orally active enkephalinase inhibitors: Their synthesis, biological activity, and analgesic properties. Bioorg Med Chem 1998, 6, 4, 441. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 48898 | 3-(benzoylsulfanyl)-2-benzylpropionic acid | C17H16O3S | 详情 | 详情 | |
(II) | 15141 | (1R,2S)-(-)-2-Amino-1,2-diphenylethanol; (1S,2R)-2-amino-1,2-diphenyl-1-ethanol | 23190-16-1 | C14H15NO | 详情 | 详情 |
(III) | 48899 | (2S)-3-(benzoylsulfanyl)-2-benzylpropionic acid | C17H16O3S | 详情 | 详情 | |
(IV) | 48900 | benzyl (4S)-4-amino-5-anilino-5-oxopentanoate | C18H20N2O3 | 详情 | 详情 | |
(V) | 48901 | benzyl (4S)-5-anilino-4-[[(2S)-3-(benzoylsulfanyl)-2-benzylpropanoyl]amino]-5-oxopentanoate | C35H34N2O5S | 详情 | 详情 |